TOP OF THE NEWS
G-2’s March survey assesses recession’s impact on labs
H1N1, health care reform highlight national priorities for industry
REGULATORY DEVELOPMENTS
CAP, ASCP join patent suit
CMS denies gene-based warfarin testing coverage
Medicare Part B spending up over 3% in 2008
INSIDE THE LAB INDUSTRY
Industry’s actions during H1N1 outbreak limited due to IP concerns
Quest develops H1N1 test
INDUSTRY NEWSMAKERS
PLUS Diagnostics opens West Coast lab
Rosetta sells Parkway Clinical Labs for $2.5 million
FINANCIAL
Lab index up 10% so far in 2009
INDUSTRY BUZZ
OIG finds improper Medicaid spending on lab services

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2009 - Table of Contents

LIR June 2009 (full PDF issue)

G-2 Reports March Survey Finds Test Volume Growth Slows to Less Than 1% During First Quarter; Lab Directors Expect 1.4% Growth for 2009

H1N1 Pandemic Threat, Health Care Overhaul Underscore Key National Priorities for Labs

CAP, ASCP Join ACLU Suit Over Breast Cancer Gene Patents

CMS Denies Reimbursement for Gene-Based Warfarin Testing; Proposes Clinical Trial Coverage

Medicare Part B Lab Spending Up 3.3% to $7.3 Billion in 2008

Inside the Lab Industry: CDC Limits Lab Industry’s Role in H1N1 Flu Diagnosis Due to IP, Reagent Supply Concerns

PLUS Diagnostics Opens West Coast Lab; Plans to Launch Hematology/Oncology Testing Services This Year

Rosetta Genomics Sells Parkway Clinical Labs for $2.5 Million in Management Buy-Out

Lab Stocks Continue to Gather Strength; Up 3% Over Five Weeks, 10% for 2009

Industry Buzz: OIG Finds Improper Medicaid Spending on Lab Services